EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 1 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -25.0% | 14,553 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 14,553 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | +40.0% | 14,553 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -37.5% | 14,553 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | +33.3% | 14,553 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -62.5% | 14,553 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | +23.1% | 14,553 | +29.1% | 0.00% | – |
| Q3 2017 | $13,000 | – | 11,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |